These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 8082736)
1. Role of topoisomerase II in the structural and functional evolution of mitogen-stimulated lymphocyte nuclei. Daev E; Chaly N; Brown DL; Valentine B; Little JE; Chen X; Walker PR Exp Cell Res; 1994 Sep; 214(1):331-42. PubMed ID: 8082736 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of topoisomerase II activity and its effect on nucleolar structure and function. Govoni M; Farabegoli F; Pession A; Novello F Exp Cell Res; 1994 Mar; 211(1):36-41. PubMed ID: 7510250 [TBL] [Abstract][Full Text] [Related]
3. DNA topoisomerase II is essential for preimplantation mouse development. St Pierre J; Wright DJ; Rowe TC; Wright SJ Mol Reprod Dev; 2002 Mar; 61(3):347-57. PubMed ID: 11835580 [TBL] [Abstract][Full Text] [Related]
4. Association of human DNA topoisomerase IIalpha with mitotic chromosomes in mammalian cells is independent of its catalytic activity. Mo YY; Beck WT Exp Cell Res; 1999 Oct; 252(1):50-62. PubMed ID: 10502399 [TBL] [Abstract][Full Text] [Related]
5. DNA topoisomerase II is required for the G0-to-S phase transition in Drosophila Schneider cells, but not in yeast. Hossain MS; Kurokawa K; Akimitsu N; Sekimizu K Genes Cells; 2004 Oct; 9(10):905-17. PubMed ID: 15461662 [TBL] [Abstract][Full Text] [Related]
6. Studies of topoisomerase-specific antitumor drugs in human lymphocytes using rabbit antisera against recombinant human topoisomerase II polypeptide. Hwang JL; Shyy SH; Chen AY; Juan CC; Whang-Peng J Cancer Res; 1989 Feb; 49(4):958-62. PubMed ID: 2536295 [TBL] [Abstract][Full Text] [Related]
7. Reversible disassembly of transcription domains in lymphocyte nuclei during inhibition of RNA synthesis by DRB. Davis L; Cadrin M; Brown DL; Chaly N Biol Cell; 1993; 78(3):163-80. PubMed ID: 7694722 [TBL] [Abstract][Full Text] [Related]
8. Drastic reduction of topoisomerase II alpha associated with major acquired resistance to topoisomerase II active agents but minor perturbations of cell growth. Hashimoto S; Chatterjee S; Ranjit GB; Bao C; Ford J; Ganapathi R; Berger SJ; Berger NA Oncol Res; 1995; 7(7-8):407-16. PubMed ID: 8747604 [TBL] [Abstract][Full Text] [Related]
9. A role of topoisomerase II in linking DNA replication to chromosome condensation. Cuvier O; Hirano T J Cell Biol; 2003 Mar; 160(5):645-55. PubMed ID: 12604590 [TBL] [Abstract][Full Text] [Related]
10. DNA topoisomerase II distribution in mouse preimplantation embryos. St Pierre J; Wright DJ; Rowe TC; Wright SJ Mol Reprod Dev; 2002 Mar; 61(3):335-46. PubMed ID: 11835579 [TBL] [Abstract][Full Text] [Related]
11. RNA synthesis inhibitors alter the subnuclear distribution of DNA topoisomerase I. Buckwalter CA; Lin AH; Tanizawa A; Pommier YG; Cheng YC; Kaufmann SH Cancer Res; 1996 Apr; 56(7):1674-81. PubMed ID: 8603419 [TBL] [Abstract][Full Text] [Related]
12. The mechanism of epipodophyllotoxin-induced thymocyte apoptosis: possible role of a novel Ca(2+)-independent protein kinase. Ye X; Georgoff I; Fleisher S; Coffman FD; Cohen S; Fresa KL Cell Immunol; 1993 Oct; 151(2):320-35. PubMed ID: 8402939 [TBL] [Abstract][Full Text] [Related]
13. Dynamic association of topoisomerase II to the mitotic chromosomes in live cells of Aspergillus nidulans. Kawagishi M; Akashi T; Kikuchi A Biochem Biophys Res Commun; 2005 Aug; 334(2):324-32. PubMed ID: 16009350 [TBL] [Abstract][Full Text] [Related]
14. Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line. Feldhoff PW; Mirski SE; Cole SP; Sullivan DM Cancer Res; 1994 Feb; 54(3):756-62. PubMed ID: 8306338 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical study of DNA topoisomerase II in human gastric disorders. Yabuki N; Sasano H; Kato K; Ohara S; Toyota T; Nagura H; Miyaike M; Nozaki N; Kikuchi A Am J Pathol; 1996 Sep; 149(3):997-1007. PubMed ID: 8780403 [TBL] [Abstract][Full Text] [Related]
16. Commitment to erythroid differentiation in mouse erythroleukemia cells is controlled by alterations in topoisomerase II alpha phosphorylation. Constantinou AI; Vaughan AT; Yamasaki H; Kamath N Cancer Res; 1996 Sep; 56(18):4192-9. PubMed ID: 8797591 [TBL] [Abstract][Full Text] [Related]
17. Organization of DNA topoisomerase II isotypes during the cell cycle of human lymphocytes and HeLa cells. Chaly N; Chen X; Dentry J; Brown DL Chromosome Res; 1996 Sep; 4(6):457-66. PubMed ID: 8889245 [TBL] [Abstract][Full Text] [Related]
18. Sequence-specific potentiation of topoisomerase II inhibitors by the histone deacetylase inhibitor suberoylanilide hydroxamic acid. Marchion DC; Bicaku E; Daud AI; Richon V; Sullivan DM; Munster PN J Cell Biochem; 2004 May; 92(2):223-37. PubMed ID: 15108350 [TBL] [Abstract][Full Text] [Related]
19. The topoisomerase II inhibitor teniposide (VM-26) induces apoptosis in unstimulated mature murine lymphocytes. Roy C; Brown DL; Little JE; Valentine BK; Walker PR; Sikorska M; Leblanc J; Chaly N Exp Cell Res; 1992 Jun; 200(2):416-24. PubMed ID: 1315287 [TBL] [Abstract][Full Text] [Related]
20. Dynamics of human DNA topoisomerases IIalpha and IIbeta in living cells. Christensen MO; Larsen MK; Barthelmes HU; Hock R; Andersen CL; Kjeldsen E; Knudsen BR; Westergaard O; Boege F; Mielke C J Cell Biol; 2002 Apr; 157(1):31-44. PubMed ID: 11927602 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]